首页 > 最新文献

Journal of Tongji Medical University = Tong ji yi ke da xue xue bao最新文献

英文 中文
A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis. 来氟米特治疗类风湿性关节炎的随机对照单盲试验。
Pub Date : 2001-01-01 DOI: 10.1007/BF02888043
Y Hu, S Tu, P Liu

The efficacy and safety of leflunomide (LEF) in the treatment of rheumatoid arthritis (RA) were evaluated and the comparison with methotrexate's (MTX's) was performed in a 12-week, single-blind, randomized, parallel trial for treating 81 patients with RA. There were 56 cases in LEF group and 25 cases in MTX group. The dose of LEF was 20 mg per day and MTX 15 mg per week. All patients took oxaproxin simultaneously at the 4th to 6th week after the trail. The results showed that the general effective rate and notable effective rate were 94.64% and 73.21% in LEF group, 72% and 44% in MTX group, respectively, with the differences being statistically significant between the two groups (P < 0.05). LEF and oxaprozin could obviously improve the symptoms, signs and joint functions. The incidence of side reactions was lower in LEF group (17.86%) than in MTX group (40.00%, P < 0.05). LEF had a good therapeutic effect for RA, especially for refractory RA and had slight side reactions, and could be regarded as a superior immunosuppressive agent used in the treatment of RA and other connective tissue diseases.

在一项为期12周的单盲、随机、平行试验中,对来氟米特(LEF)治疗类风湿性关节炎(RA)的疗效和安全性进行了评估,并与甲氨蝶呤(MTX)进行了比较,共治疗了81例RA患者。LEF组有56例,MTX组有25例。LEF剂量为每天20毫克,MTX剂量为每周15毫克。所有患者在试验后第4至第6周同时服用奥沙普酶。结果显示,LEF组的一般有效率和显著有效率分别为94.64%和73.21%,MTX组为72%和44%,两组间差异有统计学意义(P<0.05)。LEF和奥沙普秦可明显改善患者的症状、体征和关节功能。LEF组的副反应发生率(17.86%)低于MTX组(40.00%,P < 0.05)。LEF对RA尤其是难治性RA有较好的治疗效果,且副作用轻微,可作为治疗RA及其他结缔组织病的一种较好的免疫抑制剂。
{"title":"A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis.","authors":"Y Hu, S Tu, P Liu","doi":"10.1007/BF02888043","DOIUrl":"10.1007/BF02888043","url":null,"abstract":"<p><p>The efficacy and safety of leflunomide (LEF) in the treatment of rheumatoid arthritis (RA) were evaluated and the comparison with methotrexate's (MTX's) was performed in a 12-week, single-blind, randomized, parallel trial for treating 81 patients with RA. There were 56 cases in LEF group and 25 cases in MTX group. The dose of LEF was 20 mg per day and MTX 15 mg per week. All patients took oxaproxin simultaneously at the 4th to 6th week after the trail. The results showed that the general effective rate and notable effective rate were 94.64% and 73.21% in LEF group, 72% and 44% in MTX group, respectively, with the differences being statistically significant between the two groups (P < 0.05). LEF and oxaprozin could obviously improve the symptoms, signs and joint functions. The incidence of side reactions was lower in LEF group (17.86%) than in MTX group (40.00%, P < 0.05). LEF had a good therapeutic effect for RA, especially for refractory RA and had slight side reactions, and could be regarded as a superior immunosuppressive agent used in the treatment of RA and other connective tissue diseases.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52208259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on modification of the Misgav Ladach method for cesarean section. 剖腹产 Misgav Ladach 法改良研究。
Pub Date : 2001-01-01 DOI: 10.1007/BF02888044
M Li, L Zou, J Zhu

172 cases of pregnant women scheduled for delivery by cesarean section were randomly assigned to 59 cases in modification group with modified Misgav Ladach technique, 57 cases in Misgav Ladach group with Misgav Ladach technique and 56 cases in Pfannenstiel group with Pfannenstiel technique from May to Dec. 1999. The modified points included: transversely incising the fascia 2 to 3 cm, then dividing it bluntly; without opening and dissociating the visceral peritoneum; two layers suturing of low transverse uterine incision; closing the skin by continuous suturing. Results showed the average delivery time in the modification group was (3.6 +/- 2.6) min and (5.7 +/- 2.9) min in the Misgav Ladach group (P < 0.05). Median operating time was (28.3 +/- 5.4) min in modification group compared with (27.5 +/- 6.5) min in the Misgav Ladach group (P > 0.05). Average blood loss was (128 +/- 35) ml in modification group compared with (212 +/- 147) ml in the Pfannenstiel group (P < 0.05). It was concluded that the modified Misgav Ladach technique not only preserved all advantages of Misgav Ladach method, but also had additional advantages, such as faster in delivering the fetus, less damage, easier mastering for obstetricians.

1999年5月至12月,将172例计划剖宫产的孕妇随机分为改良Misgav Ladach技术的改良组59例、Misgav Ladach技术的Misgav Ladach组57例和Pfannenstiel技术的Pfannenstiel组56例。改良要点包括:横向切开筋膜 2 至 3 厘米,然后钝性分割;不打开和分离内脏腹膜;子宫低位横切口两层缝合;连续缝合皮肤。结果显示,改良组的平均分娩时间为(3.6 +/- 2.6)分钟,Misgav Ladach 组为(5.7 +/- 2.9)分钟(P < 0.05)。改良组的中位手术时间为(28.3 +/- 5.4)分钟,而 Misgav Ladach 组为(27.5 +/- 6.5)分钟(P > 0.05)。改良组的平均失血量为(128 +/- 35)毫升,而 Pfannenstiel 组为(212 +/- 147)毫升(P < 0.05)。结论是改良的 Misgav Ladach 技术不仅保留了 Misgav Ladach 方法的所有优点,还具有其他优点,如胎儿娩出更快、损伤更小、产科医生更容易掌握。
{"title":"Study on modification of the Misgav Ladach method for cesarean section.","authors":"M Li, L Zou, J Zhu","doi":"10.1007/BF02888044","DOIUrl":"10.1007/BF02888044","url":null,"abstract":"<p><p>172 cases of pregnant women scheduled for delivery by cesarean section were randomly assigned to 59 cases in modification group with modified Misgav Ladach technique, 57 cases in Misgav Ladach group with Misgav Ladach technique and 56 cases in Pfannenstiel group with Pfannenstiel technique from May to Dec. 1999. The modified points included: transversely incising the fascia 2 to 3 cm, then dividing it bluntly; without opening and dissociating the visceral peritoneum; two layers suturing of low transverse uterine incision; closing the skin by continuous suturing. Results showed the average delivery time in the modification group was (3.6 +/- 2.6) min and (5.7 +/- 2.9) min in the Misgav Ladach group (P < 0.05). Median operating time was (28.3 +/- 5.4) min in modification group compared with (27.5 +/- 6.5) min in the Misgav Ladach group (P > 0.05). Average blood loss was (128 +/- 35) ml in modification group compared with (212 +/- 147) ml in the Pfannenstiel group (P < 0.05). It was concluded that the modified Misgav Ladach technique not only preserved all advantages of Misgav Ladach method, but also had additional advantages, such as faster in delivering the fetus, less damage, easier mastering for obstetricians.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52208293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of nitric oxide in hyperoxic lung injury in premature rats. 一氧化氮在早产大鼠高氧肺损伤中的作用
Pub Date : 2001-01-01 DOI: 10.1007/BF02888045
L Chang, L Ma, X Zhang, Y Chen

To investigate the role of nitric oxide (NO) in hyperoxic lung injury, the 3-day-old preterm rats were randomly assigned to four groups: group I (hyperoxia group), group II (hyperoxia + Nw-nitro-L-arginine methyl ester (L-NAME) group), group III (air group), and group IV (air + L-NAME) group. Group I and II were exposed to > or = 90% O2 for 3 or 7 days. Group II and IV received subcutaneous L-NAMEy on daily basis (20 mg/kg). After 3 day or 7 day exposure, the lung wet weight/dry weight ratio (W/D), total protein and malondialdehyde (MDA) in bronchoalveolar lavage fluid (BALF) and lung pathology were examined in all groups. NO content, expression of endothelial NOS (eNOS) and inducible NOS (iNOS) in lungs were measured in group I and III. Our results showed that after 3 day exposure, group I appeared acute lung injury characterized by the increase of MDA content (P < 0.01) and the presence of hyperaemia, red cell extravasation and inflammatory infiltration; after 7 day exposure, except MDA, total protein and W/D were also increased in comparison with group III (P < 0.01, 0.05), pathological changes were more severe than those after 3 day exposure. After 3 and 7 day exposure, total protein in group II was significantly increased as compared with group I (P < 0.01 for both). The pulmonary acute inflammatory changes were more obvious in group II than in group I. Occasionally, mild hemorrhage was detected in the lungs of group IV. BALF protein content in group IV was higher than that in group III after 7 day exposure (P < 0.01). After 3 and 7 day exposure, NO content in BALF were all significantly elevated in group I as compared with group III (P < 0.01 for all). In the lungs of group I, strong immunostaining for iNOS was observed in airway and alveolar epithelia, inflammatory cells, which were stronger than those in group III. Expression of iNOS in rats after 7 day hyperoxic exposure was stronger than that after 3 day exposure. Shortly after 7 day exposure, stronger immunostaining for eNOS in airway epithelia in group I than that in group III was seen. Our study suggested that treatment with L-NAME worsened acute hyperoxic lung injury in preterm rats and also had a deleterious effect on the rats exposed to air, indicating that endogenous nitric oxide may play a protective role in rats under both physiological and hyperoxic status. Hyperoxia can significantly upregulate the expression of iNOS and eNOS in inflammatory cells, epithelia in the lungs of preterm rats, promote NO generation, which suggests that endogenous NO may mediate the hyperoxic pulmonary damage. Over-stimulation of iNOS may contribute to the pathogenesis of hyperoxic lung injury. NO may have dual roles in pulmonary oxygen toxicity.

为研究一氧化氮(NO)在高氧肺损伤中的作用,将3日龄早产大鼠随机分为四组:I组(高氧组)、II组(高氧+Nw-硝基-L-精氨酸甲酯(L-NAME)组)、III组(空气组)和IV组(空气+L-NAME)。第一组和第二组暴露于大于或等于 90% 的氧气中 3 天或 7 天。第二组和第四组每天皮下注射 L-NAMEy(20 毫克/千克)。暴露 3 天或 7 天后,对所有组的肺湿重/干重比(W/D)、支气管肺泡灌洗液(BALF)中的总蛋白和丙二醛(MDA)以及肺病理学进行检测。测量了 I 组和 III 组的 NO 含量、肺内皮 NOS(eNOS)和诱导性 NOS(iNOS)的表达。结果表明,暴露 3 天后,I 组出现急性肺损伤,其特征是 MDA 含量增加(P < 0.01),并出现高血症、红细胞外渗和炎症浸润;暴露 7 天后,与 III 组相比,除 MDA 外,总蛋白和 W/D 也增加(P < 0.01,0.05),病理变化比暴露 3 天后更严重。暴露 3 天和 7 天后,与 I 组相比,II 组的总蛋白显著增加(P < 0.01)。第Ⅱ组的肺部急性炎症变化比第Ⅰ组更明显,第Ⅳ组的肺部偶有轻度出血。暴露 7 天后,IV 组的 BALF 蛋白含量高于 III 组(P < 0.01)。暴露 3 天和 7 天后,与 III 组相比,I 组 BALF 中的 NO 含量均显著升高(P < 0.01)。在 I 组的肺部,气道和肺泡上皮细胞、炎症细胞中都观察到了较强的 iNOS 免疫染色,且比 III 组更强。大鼠在高氧暴露 7 天后的 iNOS 表达强于暴露 3 天后。暴露 7 天后不久,I 组气道上皮细胞的 eNOS 免疫染色强于 III 组。我们的研究表明,L-NAME 会加重早产大鼠急性高氧肺损伤,并对暴露于空气中的大鼠产生有害影响,这表明内源性一氧化氮可能对处于生理和高氧状态下的大鼠起到保护作用。高氧能显著上调早产大鼠肺部炎症细胞、上皮细胞中 iNOS 和 eNOS 的表达,促进 NO 的生成,这表明内源性 NO 可能介导了高氧肺损伤。过度刺激 iNOS 可能会导致高氧肺损伤的发病机制。NO 在肺氧毒性中可能具有双重作用。
{"title":"The role of nitric oxide in hyperoxic lung injury in premature rats.","authors":"L Chang, L Ma, X Zhang, Y Chen","doi":"10.1007/BF02888045","DOIUrl":"10.1007/BF02888045","url":null,"abstract":"<p><p>To investigate the role of nitric oxide (NO) in hyperoxic lung injury, the 3-day-old preterm rats were randomly assigned to four groups: group I (hyperoxia group), group II (hyperoxia + Nw-nitro-L-arginine methyl ester (L-NAME) group), group III (air group), and group IV (air + L-NAME) group. Group I and II were exposed to > or = 90% O2 for 3 or 7 days. Group II and IV received subcutaneous L-NAMEy on daily basis (20 mg/kg). After 3 day or 7 day exposure, the lung wet weight/dry weight ratio (W/D), total protein and malondialdehyde (MDA) in bronchoalveolar lavage fluid (BALF) and lung pathology were examined in all groups. NO content, expression of endothelial NOS (eNOS) and inducible NOS (iNOS) in lungs were measured in group I and III. Our results showed that after 3 day exposure, group I appeared acute lung injury characterized by the increase of MDA content (P < 0.01) and the presence of hyperaemia, red cell extravasation and inflammatory infiltration; after 7 day exposure, except MDA, total protein and W/D were also increased in comparison with group III (P < 0.01, 0.05), pathological changes were more severe than those after 3 day exposure. After 3 and 7 day exposure, total protein in group II was significantly increased as compared with group I (P < 0.01 for both). The pulmonary acute inflammatory changes were more obvious in group II than in group I. Occasionally, mild hemorrhage was detected in the lungs of group IV. BALF protein content in group IV was higher than that in group III after 7 day exposure (P < 0.01). After 3 and 7 day exposure, NO content in BALF were all significantly elevated in group I as compared with group III (P < 0.01 for all). In the lungs of group I, strong immunostaining for iNOS was observed in airway and alveolar epithelia, inflammatory cells, which were stronger than those in group III. Expression of iNOS in rats after 7 day hyperoxic exposure was stronger than that after 3 day exposure. Shortly after 7 day exposure, stronger immunostaining for eNOS in airway epithelia in group I than that in group III was seen. Our study suggested that treatment with L-NAME worsened acute hyperoxic lung injury in preterm rats and also had a deleterious effect on the rats exposed to air, indicating that endogenous nitric oxide may play a protective role in rats under both physiological and hyperoxic status. Hyperoxia can significantly upregulate the expression of iNOS and eNOS in inflammatory cells, epithelia in the lungs of preterm rats, promote NO generation, which suggests that endogenous NO may mediate the hyperoxic pulmonary damage. Over-stimulation of iNOS may contribute to the pathogenesis of hyperoxic lung injury. NO may have dual roles in pulmonary oxygen toxicity.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52208338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The changes of protein kinase C activity in peripheral blood lymphocytes in the patients with obstructive jaundice and the implication. 阻塞性黄疸患者外周血淋巴细胞中蛋白激酶 C 活性的变化及其影响。
Pub Date : 2001-01-01 DOI: 10.1007/BF02888073
J Wang, Q Zou, S Zou

The roles of protein kinase C (PKC) signal pathway in the pathogenesis of obstructive jaundice were studied. PKC from cytosolic and membrane fractions of peripheral blood lymphocytes (PBL) in 51 patients with obstructive jaundice and 16 cases of normal controls was isolated and purified. The activities of PKC were determined by radioactive isotope gamma-32P-ATP-catalyzing assay. The results showed that the total PKC activities in PBL in the patients with obstructive jaundice were significantly increased as compared with those in the normal controls (P < 0.01). Moreover, the membrane PKC activities and their percentages of the total PKC activities were higher in obstructive jaundice group than in those in the normal controls (P < 0.05). The total PKC activities in PBL in the patients with obstructive jaundice were significantly positively correlated with the levels of soluble IL-2 receptor (sIL-2R) (r = 0.58, P < 0.01) and the degree of jaundice (T-BIL) (r = 0.67, P < 0.01) in serum. It was concluded that the activities of PKC signal pathway was related with the degree of T-BIL. PKC signal pathway might took part in the activation of T-lymphocytes in the patients with obstructive jaundice and play an important role in the immune regulation and the assessment of pathosis in the patients with obstructive jaundice.

研究了蛋白激酶C(PKC)信号通路在阻塞性黄疸发病机制中的作用。研究人员分离并纯化了 51 例阻塞性黄疸患者和 16 例正常对照组的外周血淋巴细胞(PBL)胞浆和膜部分的 PKC。通过放射性同位素γ-32P-ATP催化测定了PKC的活性。结果显示,与正常对照组相比,阻塞性黄疸患者PBL中PKC的总活性明显升高(P < 0.01)。此外,阻塞性黄疸组的膜PKC活性及其占总PKC活性的百分比均高于正常对照组(P<0.05)。阻塞性黄疸患者PBL中的总PKC活性与血清中可溶性IL-2受体(sIL-2R)(r = 0.58,P < 0.01)和黄疸程度(T-BIL)(r = 0.67,P < 0.01)的水平呈显著正相关。结论是,PKC 信号通路的活性与 T-BIL 的程度有关。PKC信号通路可能参与了阻塞性黄疸患者T淋巴细胞的活化,并在阻塞性黄疸患者的免疫调节和病理评估中发挥重要作用。
{"title":"The changes of protein kinase C activity in peripheral blood lymphocytes in the patients with obstructive jaundice and the implication.","authors":"J Wang, Q Zou, S Zou","doi":"10.1007/BF02888073","DOIUrl":"10.1007/BF02888073","url":null,"abstract":"<p><p>The roles of protein kinase C (PKC) signal pathway in the pathogenesis of obstructive jaundice were studied. PKC from cytosolic and membrane fractions of peripheral blood lymphocytes (PBL) in 51 patients with obstructive jaundice and 16 cases of normal controls was isolated and purified. The activities of PKC were determined by radioactive isotope gamma-32P-ATP-catalyzing assay. The results showed that the total PKC activities in PBL in the patients with obstructive jaundice were significantly increased as compared with those in the normal controls (P < 0.01). Moreover, the membrane PKC activities and their percentages of the total PKC activities were higher in obstructive jaundice group than in those in the normal controls (P < 0.05). The total PKC activities in PBL in the patients with obstructive jaundice were significantly positively correlated with the levels of soluble IL-2 receptor (sIL-2R) (r = 0.58, P < 0.01) and the degree of jaundice (T-BIL) (r = 0.67, P < 0.01) in serum. It was concluded that the activities of PKC signal pathway was related with the degree of T-BIL. PKC signal pathway might took part in the activation of T-lymphocytes in the patients with obstructive jaundice and play an important role in the immune regulation and the assessment of pathosis in the patients with obstructive jaundice.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9717871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular tissue engineering: applications for modulation of mesenchymal stem cells proliferation by transforming growth factor beta 1 gene transfer. 分子组织工程:通过转化生长因子β1基因转移调节间充质干细胞增殖的应用。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886566
X Guo, J Du, Q Zheng, Y Liu, D Duan, Y Wu

The effect of transforming growth factor beta 1 (TGF-beta 1) gene transfection on the proliferation of bone marrow-derived mesenchymal stem cells (MSCs) and the mechanism was investigated to provide basis for accelerating articular cartilage repairing using molecular tissue engineering technology. TGF-beta 1 gene at different doses was transduced into the rat bone marrow-derived MSCs to examine the effects of TGF-beta 1 gene transfection on MSCs DNA synthesis, cell cycle kinetics and the expression of proliferating cell nuclear antigen (PCNA). The results showed that 3 microliters lipofectamine-mediated 1 microgram TGF-beta 1 gene transfection could effectively promote the proliferation of MSCs best; Under this condition (DNA/Lipofectamine = 1 microgram/3 microliters), flow cytometry and immunohistochemical analyses revealed a significant increase in the 3H incorporation, DNA content in S phase and the expression of PCNA. Transfection of gene encoding TGF-beta 1 could induce the cells at G0/G1 phase to S1 phase, modulate the replication of DNA through the enhancement of the PCNA expression, increase the content of DNA at S1 phase and promote the proliferation of MSCs. This new molecular tissue engineering approach could be of potential benefit to enhance the repair of damaged articular cartilage, especially those caused by degenerative joint diseases.

研究了转化生长因子β1(TGF-β1)基因转染对骨髓间充质干细胞(MSCs)增殖的影响及其机制,为利用分子组织工程技术加速关节软骨修复提供依据。研究人员将不同剂量的 TGF-beta 1 基因转入大鼠骨髓间充质干细胞,观察转染 TGF-beta 1 基因对间充质干细胞 DNA 合成、细胞周期动力学和增殖细胞核抗原(PCNA)表达的影响。结果表明,3微升脂质体转染胺介导的1微克TGF-beta 1基因转染能有效促进间充质干细胞的增殖;在此条件下(DNA/脂质体转染胺=1微克/3微升),流式细胞术和免疫组化分析显示3H掺入量、S期DNA含量和PCNA的表达均显著增加。转染编码 TGF-beta 1 的基因可诱导 G0/G1 期细胞进入 S1 期,通过增强 PCNA 表达调节 DNA 复制,增加 S1 期 DNA 含量,促进间充质干细胞增殖。这种新的分子组织工程学方法可能有助于加强受损关节软骨的修复,特别是那些由退行性关节疾病引起的关节软骨修复。
{"title":"Molecular tissue engineering: applications for modulation of mesenchymal stem cells proliferation by transforming growth factor beta 1 gene transfer.","authors":"X Guo, J Du, Q Zheng, Y Liu, D Duan, Y Wu","doi":"10.1007/BF02886566","DOIUrl":"10.1007/BF02886566","url":null,"abstract":"<p><p>The effect of transforming growth factor beta 1 (TGF-beta 1) gene transfection on the proliferation of bone marrow-derived mesenchymal stem cells (MSCs) and the mechanism was investigated to provide basis for accelerating articular cartilage repairing using molecular tissue engineering technology. TGF-beta 1 gene at different doses was transduced into the rat bone marrow-derived MSCs to examine the effects of TGF-beta 1 gene transfection on MSCs DNA synthesis, cell cycle kinetics and the expression of proliferating cell nuclear antigen (PCNA). The results showed that 3 microliters lipofectamine-mediated 1 microgram TGF-beta 1 gene transfection could effectively promote the proliferation of MSCs best; Under this condition (DNA/Lipofectamine = 1 microgram/3 microliters), flow cytometry and immunohistochemical analyses revealed a significant increase in the 3H incorporation, DNA content in S phase and the expression of PCNA. Transfection of gene encoding TGF-beta 1 could induce the cells at G0/G1 phase to S1 phase, modulate the replication of DNA through the enhancement of the PCNA expression, increase the content of DNA at S1 phase and promote the proliferation of MSCs. This new molecular tissue engineering approach could be of potential benefit to enhance the repair of damaged articular cartilage, especially those caused by degenerative joint diseases.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22204947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of in vitro cellular model predicting histocompatibility in allograft. 建立体外细胞模型,预测异体移植物的组织相容性。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886555
Y Hao, X Wu, Z Liang, P Xiong, X Jiang, F Gong

A novel in vitro cellular model producting recipient-donor histocompatibility in allograft was developed to select the donor validity. Fifteen couples of blood samples of donor and recipient in human BMT were examined using the model, and skin allograft in mice was performed to test the model. The results showed that the less the differences of histocompatibility evaluated by the model were, the later GVHR in human BMT occurred and the longer the survival time of skin allografts in mice. It was suggested that the model could be used to predict correctly histocompatibility between donor and recipient.

我们建立了一种新型体外细胞模型,在异体移植中产生受体-供体组织相容性,以选择供体的有效性。利用该模型对人类 BMT 中 15 对供体和受体的血液样本进行了检测,并对小鼠皮肤异体移植进行了测试。结果表明,模型评估的组织相容性差异越小,人类 BMT 中 GVHR 发生的时间越晚,小鼠皮肤异体移植的存活时间越长。该模型可用于正确预测供体和受体之间的组织相容性。
{"title":"Establishment of in vitro cellular model predicting histocompatibility in allograft.","authors":"Y Hao, X Wu, Z Liang, P Xiong, X Jiang, F Gong","doi":"10.1007/BF02886555","DOIUrl":"10.1007/BF02886555","url":null,"abstract":"<p><p>A novel in vitro cellular model producting recipient-donor histocompatibility in allograft was developed to select the donor validity. Fifteen couples of blood samples of donor and recipient in human BMT were examined using the model, and skin allograft in mice was performed to test the model. The results showed that the less the differences of histocompatibility evaluated by the model were, the later GVHR in human BMT occurred and the longer the survival time of skin allografts in mice. It was suggested that the model could be used to predict correctly histocompatibility between donor and recipient.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22204984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance. 急性淋巴细胞白血病BCL-1重排及其临床意义。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886557
X Liu, Z Tang

BCL-1 rearrangement (BCL-1/IgH gene rearrangement) in acute lymphocytic leukemia and its clinical significance was investigated. In 38 patients with acute lymphocytic leukemia (ALL), the genomic DNA of mononuclear cells isolated from peripheral blood and bone marrow was amplified by using hemi-nested polymerase chain reaction (PCR) technique and the expression of cyclin D1 protein of mononuclear cells was detected by using immunohistochemical method. Ten patients with acute granulocytic leukemia, 2 with chronic granulocytic leukemia and 10 with normal bone marrow served as control group. The results showed that BCL-1 rearrangement was detectable in 3 of 38 ALL patients (7.9%) and cyclin D1 protein positive expression was detected in 4 ALL patients (10.5%). Three ALL patients with BCL-1 rearrangement were all B-cell leukemia (B-ALL) and accompanied by cyclin D1 protein expression. No BCL-1/IgH rearrangement or cyclin D1 protein expression was detected in 12 patients with granulocytic leukemia and 10 cases of normal bone marrow. Leukocyte counts in peripheral blood of B-ALL patients with BCL-1 rearrangement and (or) cyclin D1 protein expression were significantly increased and the patients had bad reaction to chemotherapy. It was concluded that: 1) BCL-1/IgH gene rearrangement were detected in acute B lymphocytic leukemia; 2) B-ALL patients with BCL-1 rearrangement and (or) cyclin D1 protein expression had poor prognosis.

探讨急性淋巴细胞白血病BCL-1重排(BCL-1/IgH基因重排)及其临床意义。采用半巢式聚合酶链式反应(PCR)技术扩增38例急性淋巴细胞白血病(ALL)患者外周血和骨髓单个核细胞的基因组DNA,免疫组织化学法检测单个核细胞cyclin D1蛋白的表达。急性粒细胞白血病10例,慢性粒细胞白血病2例,正常骨髓10例作为对照组。结果显示,38例ALL患者中3例(7.9%)检测到BCL-1重排,4例(10.5%)检测到cyclin D1蛋白阳性表达。3例ALL BCL-1重排患者均为b细胞白血病(B-ALL),并伴有cyclin D1蛋白表达。12例粒细胞白血病患者和10例正常骨髓均未检测到BCL-1/IgH重排和cyclin D1蛋白表达。BCL-1重排及(或)cyclin D1蛋白表达的B-ALL患者外周血白细胞计数明显升高,化疗反应不良。结论:1)急性B淋巴细胞白血病中存在BCL-1/IgH基因重排;2) BCL-1重排和(或)cyclin D1蛋白表达的B-ALL患者预后较差。
{"title":"BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance.","authors":"X Liu,&nbsp;Z Tang","doi":"10.1007/BF02886557","DOIUrl":"https://doi.org/10.1007/BF02886557","url":null,"abstract":"<p><p>BCL-1 rearrangement (BCL-1/IgH gene rearrangement) in acute lymphocytic leukemia and its clinical significance was investigated. In 38 patients with acute lymphocytic leukemia (ALL), the genomic DNA of mononuclear cells isolated from peripheral blood and bone marrow was amplified by using hemi-nested polymerase chain reaction (PCR) technique and the expression of cyclin D1 protein of mononuclear cells was detected by using immunohistochemical method. Ten patients with acute granulocytic leukemia, 2 with chronic granulocytic leukemia and 10 with normal bone marrow served as control group. The results showed that BCL-1 rearrangement was detectable in 3 of 38 ALL patients (7.9%) and cyclin D1 protein positive expression was detected in 4 ALL patients (10.5%). Three ALL patients with BCL-1 rearrangement were all B-cell leukemia (B-ALL) and accompanied by cyclin D1 protein expression. No BCL-1/IgH rearrangement or cyclin D1 protein expression was detected in 12 patients with granulocytic leukemia and 10 cases of normal bone marrow. Leukocyte counts in peripheral blood of B-ALL patients with BCL-1 rearrangement and (or) cyclin D1 protein expression were significantly increased and the patients had bad reaction to chemotherapy. It was concluded that: 1) BCL-1/IgH gene rearrangement were detected in acute B lymphocytic leukemia; 2) B-ALL patients with BCL-1 rearrangement and (or) cyclin D1 protein expression had poor prognosis.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02886557","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22204986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma. 肝细胞癌中血管生成素-2 基因及其受体 Tie2 的表达。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886437
L Chen, Z Yang, G Wang, C Wang

To explore the relationship of angiogenesis-related angiopoietin-2 gene and its receptor Tie2 with angiogenesis and the biology of hepatocellular carcinoma (HCC), angiopoietin-2 gene, Tie2 and CD34 protein expression in 22 resected HCC, 8 cirrhotic and 8 control liver specimens were investigated by in situ hybridization and immunohistochemistry respectively, and the level of angiopoietin-2 and Tie2 expression in HCC were compared in terms of tumor biological parameters. It was found that CD34 was not expressed in control liver, expressed scarcely in cirrhotic liver (17.8 +/- 13.5/HP), but intensively expressed in HCC (86.3 +/- 34.8/HP, P < 0.01). Tie2 receptor was not expressed in controls, expressed at low level in cirrhotic liver (11.3 +/- 8.7/HP), while strongly positive in the microvascular endothelia of HCC (52.4 +/- 16.7/HP, P < 0.01). The level of Tie2 receptor expression in HCC was closely related with tumor diameter, angiogenesis and portal invasion. Angiopoietin-2 gene was not expressed in control liver, expressed mildly in cirrhotic liver (11.2 +/- 9.7/HP), but extensively in tumor zone (36.4 +/- 17.5/HP), the level of angiopoietin-2 expression was closely related with angiogenesis, portal invasion and histological grading of HCC. It is concluded that angiogenesis is increased in HCC; angiopoietin-2/Tie2 expression in human hepatic carcinoma is closely related with angiogenesis, which are probably involved in the HCC angiogenesis regulation, promoting the development and metastasis of human hepatic cancer.

为探讨血管生成相关的血管生成素-2基因及其受体Tie2与血管生成和肝细胞癌(HCC)生物学的关系,采用原位杂交和免疫组化方法分别检测了22例切除的HCC肝标本、8例肝硬化肝标本和8例对照肝标本中血管生成素-2基因、Tie2和CD34蛋白的表达,并将HCC中血管生成素-2和Tie2的表达水平与肿瘤生物学指标进行了比较。结果发现,CD34在对照组肝脏中不表达,在肝硬化肝脏中表达较少(17.8 +/- 13.5/HP),但在HCC中表达较多(86.3 +/- 34.8/HP,P < 0.01)。Tie2 受体在对照组中不表达,在肝硬化肝脏中低水平表达(11.3 +/- 8.7/HP),而在 HCC 的微血管内皮中强阳性表达(52.4 +/- 16.7/HP,P <0.01)。Tie2 受体在 HCC 中的表达水平与肿瘤直径、血管生成和门静脉侵犯密切相关。血管生成素-2基因在对照肝中不表达,在肝硬化肝中轻度表达(11.2 +/- 9.7/HP),但在肿瘤区广泛表达(36.4 +/- 17.5/HP),血管生成素-2的表达水平与血管生成、门静脉侵犯和HCC的组织学分级密切相关。结论:HCC中血管生成增加;血管生成素-2/Tie2在人类肝癌中的表达与血管生成密切相关,可能参与了HCC血管生成的调控,促进了人类肝癌的发展和转移。
{"title":"Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma.","authors":"L Chen, Z Yang, G Wang, C Wang","doi":"10.1007/BF02886437","DOIUrl":"10.1007/BF02886437","url":null,"abstract":"<p><p>To explore the relationship of angiogenesis-related angiopoietin-2 gene and its receptor Tie2 with angiogenesis and the biology of hepatocellular carcinoma (HCC), angiopoietin-2 gene, Tie2 and CD34 protein expression in 22 resected HCC, 8 cirrhotic and 8 control liver specimens were investigated by in situ hybridization and immunohistochemistry respectively, and the level of angiopoietin-2 and Tie2 expression in HCC were compared in terms of tumor biological parameters. It was found that CD34 was not expressed in control liver, expressed scarcely in cirrhotic liver (17.8 +/- 13.5/HP), but intensively expressed in HCC (86.3 +/- 34.8/HP, P < 0.01). Tie2 receptor was not expressed in controls, expressed at low level in cirrhotic liver (11.3 +/- 8.7/HP), while strongly positive in the microvascular endothelia of HCC (52.4 +/- 16.7/HP, P < 0.01). The level of Tie2 receptor expression in HCC was closely related with tumor diameter, angiogenesis and portal invasion. Angiopoietin-2 gene was not expressed in control liver, expressed mildly in cirrhotic liver (11.2 +/- 9.7/HP), but extensively in tumor zone (36.4 +/- 17.5/HP), the level of angiopoietin-2 expression was closely related with angiogenesis, portal invasion and histological grading of HCC. It is concluded that angiogenesis is increased in HCC; angiopoietin-2/Tie2 expression in human hepatic carcinoma is closely related with angiogenesis, which are probably involved in the HCC angiogenesis regulation, promoting the development and metastasis of human hepatic cancer.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22205733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of transforming growth factor-beta 2 on phagocytosis in cultured bovine trabecular meshwork cells. 转化生长因子-β2 对培养的牛小梁网状细胞吞噬功能的影响
Pub Date : 2001-01-01 DOI: 10.1007/BF02886567
Y Cao, H Wei, B Da, Y Huang

The effect of transforming growth factor-beta 2 (TGF-beta 2) on phagocytosis in bovine trabecular meshwork cells in vitro was investigated. After the cultured bovine trabecular meshwork cells were treated with 0 ng/ml, 0.32 ng/ml, 1 ng/ml, 3.2 ng/ml TGF-beta 2 for 24 h, latex beads were added into the incubation medium, and the numbers of the latex beads in 20 adjacent cells were counted under a microscope 24 h later, after treatment with Wright's stain. Our results showed that the average numbers of the latex beads in the trabecular meshwork cells treated with TGF-beta 2 of different concentrations were 53.1 +/- 1.7 beads/cell, 56.4 +/- 2.9 beads/cell and 77.9 +/- 6.5 beads/cell respectively, in comparison with 45.5 +/- 3.3 beads/cell of the control group. TGF-beta 2 significantly increased the number of the latex beads phagocytosed by cultured bovine trabecular meshwork cells in a dose-dependent manner. TGF-beta 2 could promote the phagocytosis of bovine trabecular meshwork cells in vitro. It may be involved in the cellularity decrease of the trabecular meshwork in the patients of primary open angle glaucoma through promoting the phagocytosis of trabecular meshwork cells.

研究了转化生长因子-β2(TGF-beta 2)对体外牛小梁网细胞吞噬功能的影响。用 0 ng/ml、0.32 ng/ml、1 ng/ml、3.2 ng/ml TGF-beta 2 处理牛小梁网细胞 24 小时后,在培养液中加入乳胶珠,24 小时后用赖特染色法处理,在显微镜下统计相邻 20 个细胞中乳胶珠的数量。结果显示,用不同浓度的 TGF-beta 2 处理的小梁网细胞中乳胶珠的平均数量分别为 53.1 +/- 1.7 珠/细胞、56.4 +/- 2.9 珠/细胞和 77.9 +/- 6.5 珠/细胞,而对照组为 45.5 +/- 3.3 珠/细胞。TGF-beta 2 能以剂量依赖的方式明显增加培养的牛小梁网细胞吞噬乳胶珠的数量。TGF-beta 2 可促进体外牛小梁网细胞的吞噬作用。它可能通过促进小梁网细胞的吞噬作用,参与原发性开角型青光眼患者小梁网细胞减少的过程。
{"title":"Effect of transforming growth factor-beta 2 on phagocytosis in cultured bovine trabecular meshwork cells.","authors":"Y Cao, H Wei, B Da, Y Huang","doi":"10.1007/BF02886567","DOIUrl":"10.1007/BF02886567","url":null,"abstract":"<p><p>The effect of transforming growth factor-beta 2 (TGF-beta 2) on phagocytosis in bovine trabecular meshwork cells in vitro was investigated. After the cultured bovine trabecular meshwork cells were treated with 0 ng/ml, 0.32 ng/ml, 1 ng/ml, 3.2 ng/ml TGF-beta 2 for 24 h, latex beads were added into the incubation medium, and the numbers of the latex beads in 20 adjacent cells were counted under a microscope 24 h later, after treatment with Wright's stain. Our results showed that the average numbers of the latex beads in the trabecular meshwork cells treated with TGF-beta 2 of different concentrations were 53.1 +/- 1.7 beads/cell, 56.4 +/- 2.9 beads/cell and 77.9 +/- 6.5 beads/cell respectively, in comparison with 45.5 +/- 3.3 beads/cell of the control group. TGF-beta 2 significantly increased the number of the latex beads phagocytosed by cultured bovine trabecular meshwork cells in a dose-dependent manner. TGF-beta 2 could promote the phagocytosis of bovine trabecular meshwork cells in vitro. It may be involved in the cellularity decrease of the trabecular meshwork in the patients of primary open angle glaucoma through promoting the phagocytosis of trabecular meshwork cells.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22205961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics of transmitted transfusion virus infection in children. 儿童输血病毒感染的临床特征。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886573
Z Xiong, Y Dong, F Fang, G Li

Clinical characteristics of transmitted transfusion virus (TTV) infection and its pathogenicity in children were evaluated. Serum TTV DNA from 118 children (mean age: 7.8 +/- 2.8 years) was detected by nested PCR. The product of PCR was cloned and sequenced. The positive rate for serum TTV-DNA in 20 healthy children, 9 cases of acute hepatitis, 51 cases of chronic hepatitis, 24 cases of nephritis or nephrotic syndrome and 14 cases of hypoplastic anemia or acute leukemia was 20%, 11%, 29%, 42% and 21% respectively, but there was no significant difference in TTV-DNA frequency among them (P > 0.05). Of the 16 patients receiving immunosuppressive agent for a long time, 7 (44%) were positive for TTV-DNA, and of the 17 cases not receiving immunosuppressive agent, 5 (29%) were positive with the difference being not significant (P > 0.05). Essential characteristics were pathogen-carrier or asymptomatic infection in children with TTV infection. Long-term employment of immunosuppressive agent did not increase the incidence in TTV infection. There was still high prevalence in TTV infection in healthy children not receiving blood product, suggesting the possibility of non hematogenous transmitted transfusion in TTV transmission.

对儿童输血病毒(TTV)感染的临床特征及其致病性进行了评估。通过巢式 PCR 检测了 118 名儿童(平均年龄:7.8 +/- 2.8 岁)的血清 TTV DNA。对 PCR 产物进行了克隆和测序。20名健康儿童、9名急性肝炎患者、51名慢性肝炎患者、24名肾炎或肾病综合征患者、14名发育不良性贫血或急性白血病患者的血清TTV-DNA阳性率分别为20%、11%、29%、42%和21%,但他们之间的TTV-DNA频率无显著差异(P>0.05)。在 16 例长期服用免疫抑制剂的患者中,有 7 例(44%)TTV-DNA 阳性;在 17 例未服用免疫抑制剂的患者中,有 5 例(29%)TTV-DNA 阳性,差异无显著性(P>0.05)。TTV感染儿童的基本特征是病原体携带者或无症状感染。长期使用免疫抑制剂不会增加 TTV 感染的发病率。在未接受血液制品的健康儿童中,TTV感染率仍然很高,这表明TTV传播可能与非血源性输血有关。
{"title":"Clinical characteristics of transmitted transfusion virus infection in children.","authors":"Z Xiong, Y Dong, F Fang, G Li","doi":"10.1007/BF02886573","DOIUrl":"10.1007/BF02886573","url":null,"abstract":"<p><p>Clinical characteristics of transmitted transfusion virus (TTV) infection and its pathogenicity in children were evaluated. Serum TTV DNA from 118 children (mean age: 7.8 +/- 2.8 years) was detected by nested PCR. The product of PCR was cloned and sequenced. The positive rate for serum TTV-DNA in 20 healthy children, 9 cases of acute hepatitis, 51 cases of chronic hepatitis, 24 cases of nephritis or nephrotic syndrome and 14 cases of hypoplastic anemia or acute leukemia was 20%, 11%, 29%, 42% and 21% respectively, but there was no significant difference in TTV-DNA frequency among them (P > 0.05). Of the 16 patients receiving immunosuppressive agent for a long time, 7 (44%) were positive for TTV-DNA, and of the 17 cases not receiving immunosuppressive agent, 5 (29%) were positive with the difference being not significant (P > 0.05). Essential characteristics were pathogen-carrier or asymptomatic infection in children with TTV infection. Long-term employment of immunosuppressive agent did not increase the incidence in TTV infection. There was still high prevalence in TTV infection in healthy children not receiving blood product, suggesting the possibility of non hematogenous transmitted transfusion in TTV transmission.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22205967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Tongji Medical University = Tong ji yi ke da xue xue bao
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1